Propranolol half-life
A four-hour parent-propranolol model sits within the commonly reported three-to-six-hour range.
Every curve begins at 100%. No dose or measured body concentration is assumed.
X-axis: elapsed time. Y-axis: modeled percentage of the relative starting point remaining. The shaded band shows the reported half-life range. This is a mathematical visualization, not a personal concentration estimate.
Propranolol: evidence and interpretation notes
What the representative value means
A four-hour parent-propranolol model sits within the commonly reported three-to-six-hour range. First-pass metabolism, formulation, and active metabolites prevent the line from representing every product or clinical effect.
4 hours is the single value used to make the Propranolol decline curve inspectable. The output is relative percentage remaining; it does not establish impairment, detection, or safe-activity timing.
Propranolol is included because many visitors search common medication half-lives. The curve does not answer cardiovascular, performance-anxiety, blood-pressure, or exercise-safety questions.
What each source contributes
- DailyMed: PROPRANOLOL HYDROCHLORIDE TABLET [ADVANCED RX OF TENNESSEE, LLC]. This product label adds formulation-specific pharmacokinetic context and does not represent every route or product.
- PubChem: Propranolol. This identity record confirms names and compound identity and does not supply a human half-life.
- Pharmacokinetics of propranolol: a review. This synthesis organizes the available literature and caveats and cannot replace checking the underlying study design.
For Propranolol, the numerical model is tied most closely to DailyMed: PROPRANOLOL HYDROCHLORIDE TABLET [ADVANCED RX OF TENNESSEE, LLC]. As a product label, it adds formulation-specific pharmacokinetic context; it does not represent every route or product.
Why the range stays visible
The 3-to-6-hour range is retained beside the 4-hour input for Propranolol. It is not an uncertainty slider or a personalized prediction; it shows that the cited literature does not reduce to one invariant value.
InterpretationReading the curve and its category context
Reading this curve
HalfLifeDB uses 4 h as a representative input for Propranolol. In the simplified model, about 1.6% remains after 24 hours and about 3% remains after five half-lives, or roughly 20 h.
This sits in the same-day range. The chart is useful for seeing the bend of the curve across a day or two, but it should not be treated as a personal clock. The curve is relative: it does not estimate a person's measured concentration, effects, impairment, or time to clearance.
beta-blocker context
Beta-blocker entries should be read with attention to formulation, hepatic or renal clearance, and the difference between concentration decline and physiologic effect.
- Half-life does not predict heart-rate response for an individual.
- Extended-release products can change peak timing and apparent duration.
- Clinical decisions belong with qualified medical professionals.
ComparisonTimeline checkpoints and nearby profiles
Propranolol timeline checkpoints
| Elapsed time | Modeled remaining | Reading note |
|---|---|---|
| 6 h | 35.4% | Meaningful modeled decline, not near-zero |
| 12 h | 12.5% | Long-tail portion of the model |
| 24 h | 1.56% | Low modeled remainder, not a clearance guarantee |
| 2.0 days | 0.02% | Low modeled remainder, not a clearance guarantee |
| 3.0 days | 0.00% | Low modeled remainder, not a clearance guarantee |
Nearby profiles by half-life
These entries sit near Propranolol within the beta-blocker group when sorted by representative half-life. That makes them curve comparisons, not statements about equal potency, effects, or risk.
No nearby published profiles are available in this category.
EvidencePharmacokinetic inputs and source trail
Pharmacokinetics at a glance
| Representative half-life | 4 h |
|---|---|
| Reported range | 3 h to 6 h |
| Curve type | Normalized, first-order decline |
Selection note: A four-hour parent-propranolol model sits within the commonly reported three-to-six-hour range. First-pass metabolism, formulation, and active metabolites prevent the line from representing every product or clinical effect.
Sources and evidence context
A linked record is not automatically proof of the displayed value. Study, labeling, review, and compound identity sources serve different purposes; notes below identify limitations when they are known.
- Official labeling DailyMed label: PROPRANOLOL HYDROCHLORIDE TABLET [ADVANCED RX OF TENNESSEE, LLC].Official U.S. product labeling used for formulation and labeled pharmacokinetic context; its statements apply to the described product.
- Identity record PubChem Compound Summary: Propranolol.Compound identity and naming record. It supplies chemistry context, not independent numerical support for the model.
- Research abstract PubMed: Pharmacokinetics of propranolol: a review.Direct pharmacokinetic context. Population, route, formulation, analyte, and sampling duration still determine how broadly the result can be applied.
BoundariesWhat this page cannot answer and where to continue
What this page does not answer
- It does not estimate impairment, intoxication, or fitness to drive.
- It does not predict urine, blood, saliva, or hair test results.
- It does not model repeated exposure, tolerance, withdrawal, or interactions.
- It does not replace clinician, pharmacist, toxicologist, or emergency guidance.
Continue with context
- All substance profiles
- Browse the beta-blocker group
- Compare this curve
- Clearance and volume of distribution
- Bioavailability, route, and formulation
- Active metabolites and parent compounds
- First-order vs nonlinear kinetics
- Detection windows vs half-life
- Reading labels and source quality
Read the medical disclaimer, methodology, and research standards before using the model for comparison.